AN OPEN LABEL PROSPECTIVE STUDY OF THESOLUBLE SERUM MARKER ST2 (IL-33 RECEPTOR) IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS TREATED WITH GOLIMUMAB: CLINICAL, ENDOSCOPIC AND HISTOLOGICAL RESULTS OF THE EVOLUTION STUDY
Fernando Jose Magro Dias 1
Susana Lopes 1
Marco Silva 1
Francisco Portela 2
Diogo Branquinho 2
Luis Correia 3
Samuel Fernandes 4
Marilia Lopes Cravo
Paulo Caldeira
Maria Helena Tavares Sousa
Marta Patita
Isabelle Cremers
Joana Afonso
Isabel Redondo
Patricia Machado
George Philip
Joanne Lopes
Fatima Carneiro
1 Centro Hospitalar São João,Porto,Portugal
2 Centro Hospitalar Universitário de Coimbra,Coimbra,Portugal
3 Centro Hospitalar Lisboa Norte,Lisboa,Portugal
4 Centro Hospitalar Lisboa Norte,Lisbo
Conference
UEG Week 2018
Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu